JAMES M OLESKE
Medical Practice in Greystone Park, NJ
License number
New Jersey 25MS00004000
Issued Date
Mar 3, 1992
Expiration Date
Dec 31, 1995
Category
Medical Examiners
Type
Bioanalytical Lab Dir - Spec
Address
Address
Greystone Park, NJ
Professional information
Protein-Lipid Vesicles And Autogenous Vaccine Comprising The Same
US Patent:
5834015, Nov 10, 1998
Filed:
Sep 11, 1996
Appl. No.:
8/712020
Inventors:
James M. Oleske - Morris Plains NJ
Thomas N. Denny - Cranford NJ
Anthony J. Scolpino - Ramsey NJ
Eleonora Feketeova - Harrison NJ
Raphael J. Mannino - Annandale NJ
Thomas N. Denny - Cranford NJ
Anthony J. Scolpino - Ramsey NJ
Eleonora Feketeova - Harrison NJ
Raphael J. Mannino - Annandale NJ
Assignee:
Albany Medical College - Albany NY
University of Medicine and Dentistry of New Jersey - Newark NJ
University of Medicine and Dentistry of New Jersey - Newark NJ
International Classification:
A61K 9127
US Classification:
424450
Abstract:
A protein-lipid vesicle that can be used to make an autogenous vaccine comprises patient-specific antigen, adjuvant or immunomodulator, and lipid carrier. In addition, a negatively charged lipid component is desirably included. The autogenous vaccine is useful to treat individuals with chronic diseases, including chronic infectious diseases and neoplasias. The chronic infectious diseases that can be treated include disease caused by infection with human immunodeficiency viruses.
Protein-Lipid Vesicles And Autogenous Vaccine Comprising The Same
US Patent:
6165502, Dec 26, 2000
Filed:
Nov 9, 1998
Appl. No.:
9/188120
Inventors:
James M. Oleske - Morris Plains NJ
Thomas N. Denny - Cranford NJ
Anthony J. Scolpino - Ramsey NJ
Eleonora Feketeova - Harrison NJ
Raphael J. Mannino - Annandale NJ
Thomas N. Denny - Cranford NJ
Anthony J. Scolpino - Ramsey NJ
Eleonora Feketeova - Harrison NJ
Raphael J. Mannino - Annandale NJ
Assignee:
Albany Medical College - Albany NY
Medical College of New Jersey - Newark NJ
Medical College of New Jersey - Newark NJ
International Classification:
A61K 9127
US Classification:
424450
Abstract:
A protein-lipid vesicle that can be used to make an autogenous vaccine comprises patient-specific antigen, adjuvant or immunomodulator, and lipid carrier. In addition, a negatively charged lipid component is desirably included. The autogenous vaccine is useful to treat individuals with chronic diseases, including chronic infectious diseases and neoplasias. The chronic infectious diseases that can be treated include disease caused by infection with human immunodeficiency viruses.